Cure My Disease

Don't miss your cure!

 Log in / Sign up

New hope for myeloma patients who have run out of options

NCT ID NCT04643002

Recruiting now Disease control Sponsor: Sanofi Source: ClinicalTrials.gov ↗

Summary

This study is testing several new drug combinations for people with multiple myeloma that has returned or stopped responding to standard treatments. The main goal is to find safe and effective doses and see if these new combinations can shrink the cancer. Participants will be adults who have already tried at least two other treatment lines for their myeloma.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PLASMA CELL MYELOMA REFRACTORY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Investigational Site Number : 0360001

    RECRUITING

    Richmond, Victoria, 3121, Australia

  • Investigational Site Number : 0360002

    RECRUITING

    Melbourne, Victoria, 3065, Australia

  • Investigational Site Number : 0360006

    RECRUITING

    Wollongong, New South Wales, 2500, Australia

  • Investigational Site Number : 2500001

    RECRUITING

    Nantes, 44093, France

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Investigational Site Number : 2500002

    RECRUITING

    Lille, 59037, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Investigational Site Number : 2500003

    RECRUITING

    Paris, Washington, 75651, France

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Investigational Site Number : 2500004

    RECRUITING

    Paris, 75015, France

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Investigational Site Number : 2760006

    RECRUITING

    Frankfurt, 60590, Germany

  • Investigational Site Number : 2760008

    RECRUITING

    Lübeck, 23538, Germany

  • Investigational Site Number : 3000001

    RECRUITING

    Athens, 115 28, Greece

  • Investigational Site Number : 3000002

    RECRUITING

    Athens, 106 76, Greece

  • Investigational Site Number : 3760001

    RECRUITING

    Tel Aviv, 6423906, Israel

  • Investigational Site Number : 3760002

    RECRUITING

    Jerusalem, 9112001, Israel

  • Investigational Site Number : 3760003

    RECRUITING

    Ramat Gan, 5262100, Israel

  • Investigational Site Number : 3800001

    RECRUITING

    Meldola, Reggio Emilia, 47014, Italy

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Investigational Site Number : 4100001

    RECRUITING

    Seoul, Seoul-teukbyeolsi, 03080, South Korea

  • Investigational Site Number : 4100002

    RECRUITING

    Seoul, Seoul-teukbyeolsi, 06351, South Korea

  • Investigational Site Number : 4100003

    RECRUITING

    Seoul, Seoul-teukbyeolsi, 06591, South Korea

  • Investigational Site Number : 4100004

    RECRUITING

    Seoul, Seoul-teukbyeolsi, 03722, South Korea

  • Investigational Site Number : 5780001

    RECRUITING

    Oslo, 0450, Norway

  • Investigational Site Number : 6200001

    RECRUITING

    Coimbra, 3000-075, Portugal

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Investigational Site Number : 6200002

    RECRUITING

    Porto, 4434-502, Portugal

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Puerto Rico Medical Research Center- Site Number : 8400005

    RECRUITING

    Hato Rey, Puerto Rico, 00917, Puerto Rico

  • Roswell Park Cancer Institute- Site Number : 8400008

    RECRUITING

    Buffalo, New York, 14263, United States

  • The Ohio State University- Site Number : 8400012

    RECRUITING

    Columbus, Ohio, 43210, United States

  • University of Illinois-Chicago - College of Medicine- Site Number : 8400007

    COMPLETED

    Chicago, Illinois, 60612, United States

  • University of Michigan Health System - Ann Arbor- Site Number : 8400004

    RECRUITING

    Ann Arbor, Michigan, 48109, United States

  • Winship Cancer Institute of Emory University- Site Number : 8400010

    RECRUITING

    Atlanta, Georgia, 30322, United States

Conditions

Explore the condition pages connected to this study.

PLASMA CELL MYELOMA REFRACTORY